France Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342753
  • Report
  • Region: France
  • 158 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • Pfizer Inc
  • MORE
France Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "France Drug Delivery Devices Market Outlook to 2023", provides key market data on the France Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the France Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • Pfizer Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, France
3.1 Drug Delivery Devices Market, France, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, France, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, France, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, France, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, France, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, France, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, France, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, France, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, France, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, France
4.1 Central Venous Catheters Market, France, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, France, Segment Contribution (%), 2016
4.3 Central Venous Catheters Market, France, Revenue ($m), 2009-2016
4.4 Central Venous Catheters Market, France, Revenue ($m), 2016-2023
4.5 Central Venous Catheters Market, France, Volume (Units), 2009-2016
4.6 Central Venous Catheters Market, France, Volume (Units), 2016-2023
4.7 Central Venous Catheters Market, France, Distribution Share by Revenue ($m), 2015-2016
4.8 Central Venous Catheters Market, France, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, France
5.1 Infusion Systems Market, France, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, France, Segment Contribution (%), 2016
5.3 Infusion Systems Market, France, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, France, Revenue ($m), 2016-2023
5.4.1 Ambulatory Infusion Pumps Market, France, Revenue ($m), by Segment, 2009-2016
5.4.2 Syringe Pumps Market, France, Revenue ($m), by Segment, 2009-2016
5.4.3 Ambulatory Infusion Pumps Market, France, Revenue ($m), by Segment, 2016-2023
5.4.4 Syringe Pumps Market, France, Revenue ($m), by Segment, 2016-2023
5.5 Infusion Systems Market, France, Volume (Units), 2009-2016
5.6 Infusion Systems Market, France, Volume (Units), 2016-2023
5.6.1 Ambulatory Infusion Pumps Market, France, Volume (Units), by Segment, 2009-2016
5.6.2 Syringe Pumps Market, France, Volume (Units), by Segment, 2009-2016
5.6.3 Ambulatory Infusion Pumps Market, France, Volume (Units), by Segment, 2016-2023
5.6.4 Syringe Pumps Market, France, Volume (Units), by Segment, 2016-2023
5.7 Infusion Systems Market, France, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, France, Company Share by Revenue ($m), 2016
6 Metered Dose Inhaler Devices Market, France
6.1 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2009-2016
6.2 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2016-2023
6.3 Metered Dose Inhaler Devices Market, France, Volume (Units), 2009-2016
6.4 Metered Dose Inhaler Devices Market, France, Volume (Units), 2016-2023
6.5 Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), 2015-2016
6.6 Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), 2016
7 Needle Free Injections Market, France
7.1 Needle Free Injections Market, France, Revenue ($m), 2009-2016
7.2 Needle Free Injections Market, France, Revenue ($m), 2016-2023
7.3 Needle Free Injections Market, France, Volume (Units), 2009-2016
7.4 Needle Free Injections Market, France, Volume (Units), 2016-2023
7.5 Needle Free Injections Market, France, Distribution Share by Revenue ($m), 2015-2016
7.6 Needle Free Injections Market, France, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in France, Drug Delivery Devices Market
8.1 B. Braun Melsungen AG
8.1.1 Company Overview
8.2 GlaxoSmithKline Plc
8.2.1 Company Overview
8.3 Baxter International Inc
8.3.1 Company Overview
8.4 AstraZeneca Plc
8.4.1 Company Overview
8.5 Becton Dickinson and Co
8.5.1 Company Overview
8.6 Boehringer Ingelheim GmbH
8.6.1 Company Overview
8.7 Fresenius Kabi AG
8.7.1 Company Overview
8.8 Pfizer Inc
8.8.1 Company Overview
8.9 Merck & Co Inc
8.9.1 Company Overview
8.10 Medtronic Plc
8.10.1 Company Overview
8.11 Smiths Medical
8.11.1 Company Overview
8.12 Terumo Corp
8.12.1 Company Overview
8.13 Hospira Inc
8.13.1 Company Overview
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Asset Transactions
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
10.2 Partnerships
10.2.1 Alimera Sciences Enters into Licensing Agreement with pSivida
10.2.2 Bluegrass Vascular Enters into Partnership with Merit Medical
10.2.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
10.2.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
10.2.5 Propeller Health Enters into Agreement with Novartis Pharma
10.2.6 Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology
10.2.7 Pfizer Terminates its Licensing Agreement with pSivida
10.2.8 Biocorp Production Enters into Licensing Agreement
10.2.9 Bayer Enters into Licensing Agreement with DelSiTech
10.2.10 BioCorRx Enters into Licensing Agreement with Therakine
11 Recent Developments
11.1 Corporate Communications
11.1.1 Jun 28, 2017: Cellectis Appoints Rainer Boehm, M.D. and Herve Hoppenot to Board of Directors
11.1.2 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
11.1.3 Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication
11.1.4 Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
11.1.5 Mar 30, 2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce
11.1.6 Mar 06, 2017: EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the US
11.1.7 Mar 02, 2017: Sanofi’s Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors
11.1.8 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
11.1.9 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs
11.1.10 Jan 03, 2017: Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer
11.1.11 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare
11.1.12 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation
11.1.13 Sep 06, 2016: Sanofi Board Of Directors Provides Update
11.2 Financial Announcements
11.2.1 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication
11.2.2 May 17, 2017: EDAP TMS SA Reports First Quarter 2017 Results
11.2.3 May 09, 2017: Cellectis Reports 1st Quarter 2017 Financial Results
11.2.4 May 09, 2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results
11.2.5 Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results
11.2.6 Apr 03, 2017: EDAP Achieves 63% Growth in HIFU Revenue in 2016
11.2.7 Mar 07, 2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results
11.2.8 Mar 06, 2017: Cellectis Reports 4th Quarter and Full Year 2016 Financial Results
11.2.9 Feb 23, 2017: EDAP Announces Preliminary Unaudited Full Year 2016 Revenue
11.2.10 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER
11.2.11 Nov 22, 2016: Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016
11.2.12 Nov 17, 2016: EDAP Achieves 79% Growth in HIFU Revenue for First Nine Months of 2016
11.2.13 Nov 07, 2016: Flamel Technologies Reports Third Quarter 2016 Results
11.2.14 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results
11.2.15 Sep 08, 2016: Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results
11.2.16 Aug 25, 2016: EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016
11.2.17 Jul 29, 2016: Sanofi Announces Q2 2016 Results
11.2.18 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi
11.3 Other Significant Developments
11.3.1 Feb 08, 2017: Dr. Reddy's Expands Commercial Operations in Europe
11.3.2 Jan 05, 2017: Avadel Pharmaceuticals Provides 2017 Guidance and Business Update
11.4 Product News
11.4.1 Nov 14, 2016: Aguettant's Range of Emergency Injectable Medicine in Ready-to-administer Syringes is Going Global
11.5 Strategy And Business Planning
11.5.1 Nov 21, 2016: UNITHER Pharmaceuticals opens a Chinese subsidiary: Unither Pharmaceutical Technologies
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Company Share Analysis
12.1.5 Distribution Share Analysis
12.1.6 Benchmarking
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, France, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, France, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, France, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, France, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, France, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, France, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, France, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, France, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, France, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, France, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, France, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, France, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, France, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, France, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, France, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, France, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016
Table 35: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023
Table 36: Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Needle Free Injections Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Needle Free Injections Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Needle Free Injections Market, France, Volume (Units), Historic, 2009-2016
Table 41: Needle Free Injections Market, France, Volume (Units), Forecast, 2016-2023
Table 42: Needle Free Injections Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Needle Free Injections Market, France, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 46: Alimera Sciences Enters into Licensing Agreement with pSivida
Table 47: Bluegrass Vascular Enters into Partnership with Merit Medical
Table 48: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 49: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 50: Propeller Health Enters into Agreement with Novartis Pharma
Table 51: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology
Table 52: Pfizer Terminates its Licensing Agreement with pSivida
Table 53: Biocorp Production Enters into Licensing Agreement
Table 54: Bayer Enters into Licensing Agreement with DelSiTech
Table 55: BioCorRx Enters into Licensing Agreement with Therakine

List of Figures
Figure 1: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, France, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, France, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, France, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, France, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, France, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, France, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, France, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, France, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, France, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, France, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, France, Company Share (%) 2016
Figure 18: Infusion Systems Market, France, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, France, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, France, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, France, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, France, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, France, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, France, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, France, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, France, Company Share (%) 2016
Figure 33: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016
Figure 36: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023
Figure 37: Metered Dose Inhaler Devices Market, France, Company Share (%) 2016
Figure 38: Needle Free Injections Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Needle Free Injections Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Needle Free Injections Market, France, Volume (Units), Historic, 2009-2016
Figure 41: Needle Free Injections Market, France, Volume (Units), Forecast, 2016-2023
Figure 42: Needle Free Injections Market, France, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • GlaxoSmithKline Plc
  • Baxter International Inc
  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Pfizer Inc
  • Merck & Co Inc
  • Medtronic Plc
  • Smiths Medical
  • Terumo Corp
  • Hospira Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll